Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...
Ascendis Pharma and Novo Nordisk announced a partnership to develop cardiovascular and metabolic drugs that utilize Ascendis’ drug-delivery technology. Lamassu Biotech expanded to ... from its amylin ...
Back, that is, from a U.S. prison halfway around the world. Yet the crypto billionaire known as CZ isn’t back at the helm of the largest crypto exchange, since his plea deal with the U.S. Department ...